BioNTech
BNTXBioNTech SE (German pronunciation:) is a German biotechnology company dedicated to the development and manufacture of active immunotherapies for a patient-specific approach to the treatment of serious diseases. It researches drugs based on messenger RNA (mRNA) for use as individualized cancer immuno …
© Wikipedia /
Creative Commons CC-BY-SA 3.0
more at Wikipedia
Insider trades and stock quote 2024-2026
All insider trades at BioNTech
Subscribe RSS| Date | Type | Ø-Price | Volume |
|---|---|---|---|
| 9/30/2026 | Sell | $98.1 | $3,139,850 |
| 9/29/2026 | Sell | $98.3 | $3,340,809 |
| 9/28/2026 | Sell | $98.5 | $3,347,919 |
| 9/25/2026 | Sell | $98.7 | $2,664,581 |
| 9/24/2026 | Sell | $99.0 | $3,860,661 |
| 9/23/2026 | Sell | $99.4 | $2,982,081 |
| 9/22/2026 | Sell | $100.7 | $4,633,037 |
| 9/21/2026 | Sell | $97.8 | $3,227,720 |
| 9/18/2026 | Sell | $96.2 | $2,886,729 |
| 9/17/2026 | Sell | $98.6 | $3,352,342 |
| 9/16/2026 | Sell | $96.1 | $1,441,340 |
| 9/15/2026 | Sell | $96.5 | $3,280,636 |
| 9/14/2026 | Sell | $99.4 | $4,077,315 |
| 9/11/2026 | Sell | $96.9 | $4,362,021 |
| 9/10/2026 | Sell | $96.3 | $1,974,287 |
| 9/9/2026 | Sell | $97.8 | $3,520,145 |
| 9/8/2026 | Sell | $99.2 | $3,670,518 |
| 9/4/2026 | Sell | $103.5 | $3,260,823 |
| 9/3/2026 | Sell | $102.8 | $4,628,232 |
| 4/22/2026 | Sell | $110.6 | $5,527,960 |
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)